NovaBay Pharmaceuticals, Inc. (SDEV) Stock Analysis & Investment Frameworks
NovaBay Pharmaceuticals, Inc. (SDEV) stock analysis on Invetso. Review NovaBay Pharmaceuticals, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
NovaBay Pharmaceuticals, Inc. Company Overview
- Exchange: New York Stock Exchange Arca
- Sector: Financial Services
- Industry: Asset Management - Cryptocurrency
- Country: US
NovaBay Pharmaceuticals, Inc. Key Financial Metrics
- Market Cap: $45.58M
- Revenue: $N/A
- ROE: 789.69%
- ROIC: -5.18%
- Dividend Yield: 454.13%
About NovaBay Pharmaceuticals, Inc.
Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaBay Pharmaceuticals, Inc. and changed its name to Stablecoin Development Corporation in April 2026. Stablecoin Development Corporation was incorporated in 2000 and is headquartered in Emeryville, California.
NovaBay Pharmaceuticals, Inc. Investment Frameworks
Invetso analyzes NovaBay Pharmaceuticals, Inc. (SDEV) across the following frameworks:
- NovaBay Pharmaceuticals, Inc. 10Y Growth Potential
- NovaBay Pharmaceuticals, Inc. Scenario Analysis
- NovaBay Pharmaceuticals, Inc. Risks & Opportunities
- NovaBay Pharmaceuticals, Inc. Economic Moat
- NovaBay Pharmaceuticals, Inc. Business Model
- NovaBay Pharmaceuticals, Inc. Management
- NovaBay Pharmaceuticals, Inc. SWOT Analysis
- NovaBay Pharmaceuticals, Inc. Porter's 5 Forces
- NovaBay Pharmaceuticals, Inc. PESTLE Analysis
- NovaBay Pharmaceuticals, Inc. ESG Analysis